Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Cited Article

Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014 promotion: free to download

Volume:21   Issue:3
Pp: 302-317
Yan Xiao and Yajun Liu*
DOI: 10.2174/1389450120666190829162544

Bioinformatics Approaches for Anti-cancer Drug Discovery promotion: free to download

Volume:21   Issue:1
Pp: 3-17
Kening Li, Yuxin Du, Lu Li and Dong-Qing Wei*
DOI: 10.2174/1389450120666190923162203

Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer promotion: free to download

Volume:21   Issue:3
Pp: 258-278
Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*
DOI: 10.2174/1389450120666190821160730

The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy promotion: free to download

Volume:21   Issue:3
Pp: 288-301
Lin Zhou, Luyao Ao, Yunyi Yan, Wanting Li, Anqi Ye, Yahui Hu*, Weirong Fang* and Yunman Li*
DOI: 10.2174/1389450120666190906153652

TNF-α and IL-6: The Link between Immune and Bone System

Volume:21   Issue:3
Pp: 213-227
Tiantian Wang and Chengqi He*
DOI: 10.2174/1389450120666190821161259

Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases

Volume:21   Issue:2
Pp: 105-124
Dhurvas Chandrasekaran Dinesh*, Selvaraj Tamilarasan, Kaushik Rajaram and Evžen Bouřa*
DOI: 10.2174/1389450119666190920153247

N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases

Volume:21   Issue:11
Pp: 1056-1067
Hui Zhong, Hui-Fang Tang and Yin Kai*
DOI: 10.2174/1389450121666200210125247

The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas

Volume:21   Issue:10
Pp: 946-961
Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan
DOI: 10.2174/1389450120666191120123612

IL-37 As a Potential Biotherapeutics of Inflammatory Diseases

Volume:21   Issue:9
Pp: 855-863
Junhui Bai, Yukun Li, Meixiang Li, Sijie Tan* and Daichao Wu*
DOI: 10.2174/1389450121666200429114926

ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors promotion: free to download

Volume:21   Issue:9
Pp: 892-901
Ana Luiza Ataide Carneiro de Paula Gonzaga , Vitória Andrade Palmeira , Thomas Felipe Silva Ribeiro , Larissa Braga Costa , Karla Emília de Sá Rodrigues and Ana Cristina Simões-e-Silva *
DOI: 10.2174/1389450121666200210124217

Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies

Volume:21   Issue:9
Pp: 864-891
Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikramdeep Monga and Bhupinder Kumar*
DOI: 10.2174/1389450121666200310115327

Nanosized Modification Strategies for Improving the Antitumor Efficacy of MEK Inhibitors

Volume:21   Issue:3
Pp: 228-251
Yanan Li, Qingrong Dong, Ting Mei, Meichen Zheng, Ramasamy Raj Kumar, Bin Yu, Chunsheng Wu, Hui Zhang* and Feifei An*
DOI: 10.2174/1389450120666190807143245

Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance

Volume:21   Issue:2
Pp: 167-178
Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui and Liying Han*
DOI: 10.2174/1389450120666190925123507

Computational Advances in Chronic Diseases Diagnostics and Therapy - I promotion: free to download

Volume:21   Issue:1
Pp: 1-2
Gurudeeban Selvaraj, Chandrabose Selvaraj and Dong-Qing Wei
DOI: 10.2174/138945012101191206142040

BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer

Volume:21   Issue:10
Pp: 962-973
Amal Tazzite*, Hassan Jouhadi, Abdellatif Benider and Sellama Nadifi
DOI: 10.2174/1389450121666200203162541

Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review

Volume:21   Issue:8
Pp: 781-791
Samira Asgharzade, Andisheh Talaei, Tahereh Farkhondeh and Fatemeh Forouzanfar*
DOI: 10.2174/1389450121666200107100747

Angiotensin Type 1 Receptor Blockers in Heart Failure

Volume:21   Issue:2
Pp: 125-131
Khuraijam Dhanachandra Singh* and Sadashiva S. Karnik*
DOI: 10.2174/1389450120666190821152000

PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay

Volume:21   Issue:16
Pp: 1664-1671
Alessia Cimadamore*, Francesco Massari , Matteo Santoni, Antonio Lopez-Beltran , Liang Cheng , Marina Scarpelli, Rodolfo Montironi and Holger Moch
DOI: 10.2174/1389450121666200324151056

Fluoroquinolones: Blessings Or Curses

Volume:21   Issue:13
Pp: 1354-1370
Priyanka P. Majalekar* and Pramodkumar J. Shirote
DOI: 10.2174/1389450121666200621193355

Immunotherapy and Radiation Therapy in Renal Cell Carcinoma

Volume:21   Issue:14
Pp: 1463-1475
Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi and Francesco Massari*
DOI: 10.2174/1389450121666200311121540

Use of Anti-VEGF Drugs in Retinal Vein Occlusions

Volume:21   Issue:12
Pp: 1181-1193
Manuel AP Vilela*
DOI: 10.2174/1389450121666200428101343